Yawei Shi

Title: The Innovative Contributions of Yawei Shi

Introduction

Yawei Shi is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmacology, particularly in the development of kappa-opioid receptor antagonists. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Yawei Shi holds a patent for "Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto." This patent discloses a solid Form A of a specific compound, which exhibits distinct X-ray diffraction patterns. The solid Form A is recognized for its potential therapeutic applications in treating conditions that benefit from kappa-opioid receptor antagonism.

Career Highlights

Shi is currently associated with Neumora Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new treatments that leverage the properties of kappa-opioid receptor antagonists. With a focus on innovation, he has successfully navigated the complexities of drug development.

Collaborations

Throughout his career, Yawei Shi has collaborated with notable colleagues, including Brian Van Dyke and Mengya Ma. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Yawei Shi's contributions to the field of pharmacology exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Neumora Therapeutics, Inc. highlight his dedication to improving healthcare through scientific advancements.